FDA Approves Two Dako Assays as Companion Diagnostics for Genentech’s New Breast Cancer Medicine Kadcyla

Posted: March 5th, 2013  |  Company/topic: Genentech
Website: Marketwire - Breaking News Releases (English Only)
GLOSTRUP, DENMARK--(Marketwire - Mar 5, 2013) - Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, announced today it has received approval from the U.S. Food and Dru…
Tags: , ,

FDA Approves Two Dako Assays as Companion Diagnostics for Genentech’s New Breast Cancer Medicine Kadcyla

Posted: March 5th, 2013  |  Company/topic: Genentech
Website: Marketwire - Breaking News Releases (English Only)
GLOSTRUP, DENMARK--(Marketwire - Mar 5, 2013) - Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, announced today it has received approval from the U.S. Food and Dru…
Tags: , ,

Dako, Pfizer collaborate on companion diagnostics

Posted: February 14th, 2013  |  Company/topic: Pfizer
Website: CenterWatch News Online Headlines
Dako, a tissue-based cancer diagnostics company based in Denmark, has entered into a collaboration agreement with Pfizer in the field of companion diagnostics.
Tags: , ,

Cancer Genetics, Inc. Selected by Roche Servicios S.A. to Provide Services for the Diagnosis and Personalization of Oncology Treatment

Posted: August 3rd, 2012  |  Company/topic: Roche
Website: Biomarker Commons
Cancer Genetics, Inc. (CGI), a leader in cancer diagnostics, announces that it has been selected by Roche Servicios S.A., an affiliate of the Swiss drug maker Roche based in Costa Rica, as its...Read…
Tags: , , , ,